Insider Cluster (2 insiders) ·Filed Jul 15, 2026

ORKA

Oruka Therapeutics, Inc.
NEUTRAL
Impact 2/10
Horizonimmediate Processed2mo ago
Insider cluster: 2 insiders, $239K total
Actionable Insight • Neutral

No material signal from this insider cluster given the negligible dollar amount relative to market cap. Monitor for upcoming catalysts (e.g., clinical data, pipeline updates) that could drive the stock, but this filing alone does not warrant a trading action.

DirectionNeutral
Confidencehigh
Horizonimmediate
Latest settled — T+20d
ORKA ▲ +30.20% at T+20d
NEUTRAL call ✓ call won +30.20% · α vs SPY +26.58% · entry $83.04 → $108.12
Next anchor: T+60d in 6d
Latest observation: T+54 +0.78% FF3 residual α
Entry anchored
Jul 15, 03:59 PM ET
via exchange tick
T+1d
+11.63%
call +11.63% · α +12.62%
$92.70
settled 3mo ago
T+5d
+10.73%
call +10.73% · α +12.40%
$91.95
settled 2mo ago
T+20d
+30.20%
call +30.20% · α +26.58%
$108.12
settled 7w ago
T+60d
—
call — · α —
—
in 6d

Price Chart

Loading chart...

Executive Summary

Two insiders (CMO and SVP Finance) sold shares totaling ~$1.45M, but this represents only 0.027% of the $5.3B market cap, making it a routine and immaterial event. The sales appear tied to option exercises and are not indicative of a bearish view.

Key Financial Metrics

Direction
selling
Total Value
$1.5M
Insiders
2

Key Facts

  • CMO Joana Goncalves sold ~$604K in open-market sales on July 15, 2026, following option exercises.
  • SVP Finance Arjun Agarwal sold ~$846K in open-market sales on July 13, 2026, following option exercises.
  • Total open-market sales of ~$1.45M represent 0.027% of ORKA's $5.3B market cap.
  • All sales were preceded by derivative exercises (cash and non-cash), consistent with routine tax or diversification planning.

Financial Impact

Total insider sales of ~$1.45M are trivial relative to $5.3B market cap (0.027%).

dilution

Risk Factors

  • Insider sales could increase if the stock continues to appreciate, but current volume is immaterial.
  • Lack of C-suite (CEO/CFO) participation reduces informational content of the cluster.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
95% bullish (20 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-ORKA-1784160084727
26 reports for ORKA
Performance horizon
100% Hit rate 11 of 11 directional calls best @ T+60▲ +80.05%Jun 1, 2026
Filters
Rows
Reports for ORKA — sortable, filterable
TypeNow
Sep 15, 2026
16d ago
Insider Cluster
NEUTRAL ★ 3/10
$93.55 $89.93▼ −3.87%▼ −6.44%$84.38 (−9.80%)
Sep 1, 2026
4w ago
Insider Cluster
BEARISH ★ 4/10
$91.63 $91.65▼ −0.02%▼ −0.98%$84.38 (+7.91%)
Aug 28, 2026
5w ago
EFFECT
BEARISH ★ 6/10
$91.15 $92.51▼ −1.50%▼ −1.39%$84.38 (+7.42%)
Aug 17, 2026
6w ago
Insider Cluster
NEUTRAL ★ 2/10
$113.08 $101.82▼ −9.96%▼ −9.76%$84.38 (−25.38%)
Aug 10, 2026
7w ago
Press Release
BULLISH ★ 7/10
$105.14 $112.66▲ +7.15%▲ +7.20%$84.38 (−19.75%)
Aug 10, 2026
7w ago
8-K
BULLISH ★ 6/10
$105.14 $112.66▲ +7.15%▲ +7.20%$84.38 (−19.75%)
Aug 9, 2026
7w ago
Institutional Cluster
BULLISH ★ 7/10
$105.14 $112.66▲ +7.15%▲ +7.20%$84.38 (−19.75%)
Jul 15, 2026
11w ago
Insider Cluster
NEUTRAL ★ 2/10
$83.04 $91.95▲ +10.73%▲ +12.40%$84.38 (+1.61%)
Jul 2, 2026
13w ago
Insider Cluster
NEUTRAL ★ 5/10
$85.21 $88.27▲ +3.59%▲ +2.66%$84.38 (−0.97%)
Jun 22, 2026
14w ago
Insider Cluster
NEUTRAL ★ 3/10
$83.40 $92.49▲ +10.90%▲ +9.89%$84.38 (+1.18%)
Showing 10 of 26

US Market Status

Market Open — Closes in 3h 53m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Jul 16, 2026